Pear Therapeutics Profit Margin

As of the most recent data (December 2022), PEAR shows a profit margin of 195.19%. That compares with -2220.12% in the prior-year period — up 108.8% year over year. That is above the sector sector average of 19.69%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PEAR's profit margin is now 195.19% (was -2220.12%) — a 108.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Pear Therapeutics is outperforming or lagging.

The its sector sector average profit margin is about 19.69%. Pear Therapeutics is at 195.19%, which is higher that average. That is roughly 891.2% above the sector mean. Use the comparison chart on this page to see how PEAR stacks up against individual peers as well.

That compares with -2220.12% in the prior-year period — up 108.8% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Pear Therapeutics with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Pear Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 195.19%) with ownership activity and broader fundamentals.